Lynsight

Lynsight provides reliable Lynch syndrome diagnostics through our functional test, DiagMMR. Our mission is to empower families and healthcare professionals to make better-informed decisions for cancer prevention. Lynch syndrome is the main cause of hereditary cancers, yet many of the millions of affected people are unaware of having Lynch syndrome and the related highly increased risk for cancer. Our groundbreaking DiagMMR assay is a reliable functional test that can be used for detecting MMR deficiency, the hallmark of Lynch syndrome. Our mission is to provide reliable Lynch syndrome diagnostics to empower families and healthcare professionals to make better informed decisions...

Diagnostics,molecular diagnostics,mmr,functional assay,lynch syndrome,inherited cancer,hereditary cancer,hnpcc,predictive diagnostics,and in vitro diagnostics

Lynsight operates in the Medical equipment manufacturing industry.

Lynsight's revenue is 11m - 100m

Lynsight has 11 - 50 employees.